Lipella Pharmaceuticals (NASDAQ:LIPO) versus Wellness Center USA (OTCMKTS:WCUI) Head-To-Head Contrast

Lipella Pharmaceuticals (NASDAQ:LIPO) and Wellness Center USA (OTCMKTS:WCUI) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, valuation, dividends, profitability, earnings, analyst recommendations and risk.

Earnings & Valuation

This table compares Lipella Pharmaceuticals and Wellness Center USA”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Lipella Pharmaceuticals	$450,000.00	70.70	-$4.62 million	($0.60)	-5.48
Wellness Center USA	$660,000.00	0.06	-$750,000.00	N/A	N/A

Wellness Center USA has higher revenue and earnings than Lipella Pharmaceuticals.

Analyst Ratings

This is a breakdown of current recommendations for Lipella Pharmaceuticals and Wellness Center USA, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Lipella Pharmaceuticals	0	0	1	0	3.00
Wellness Center USA	0	0	0	0	0.00

Lipella Pharmaceuticals presently has a consensus target price of $2.00, indicating a potential downside of 39.21%. Given Lipella Pharmaceuticals’ stronger consensus rating and higher probable upside, analysts plainly believe Lipella Pharmaceuticals is more favorable than Wellness Center USA.

Volatility and Risk

Lipella Pharmaceuticals has a beta of 0.31, indicating that its stock price is 69% less volatile than the S&P 500. Comparatively, Wellness Center USA has a beta of 1.69, indicating that its stock price is 69% more volatile than the S&P 500.

Profitability

This table compares Lipella Pharmaceuticals and Wellness Center USA’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Lipella Pharmaceuticals	-817.16%	-172.07%	-141.17%
Wellness Center USA	N/A	N/A	N/A

Insider & Institutional Ownership

74.3% of Lipella Pharmaceuticals shares are owned by institutional investors. Comparatively, 0.0% of Wellness Center USA shares are owned by institutional investors. 37.0% of Lipella Pharmaceuticals shares are owned by insiders. Comparatively, 15.7% of Wellness Center USA shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

About Lipella Pharmaceuticals

Lipella Pharmaceuticals Inc., a biotechnology company, focuses on developing drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for various applications. The company develops LP-10, a formulation of tacrolimus that has completed Phase 2a clinical trial for patients with radiation-induced hemorrhagic cystitis; LP-310, a formulation of tacrolimus for the treatment of oral lichen planus; and LP-410, an oral liposomal formulation of tacrolimus for the treatment of oral graft-versus-host disease (GVHD). Lipella Pharmaceuticals Inc. was incorporated in 2005 and is headquartered in Pittsburgh, Pennsylvania.

About Wellness Center USA

Wellness Center USA, Inc. engages in the healthcare and medical business in the United States and internationally. The company operates through Medical Devices; and Authentication and Encryption Products and Services segments. It is primarily involved in the marketing and distribution of online sports and nutrition supplements. The company also designs, develops, manufactures, markets, and distributes targeted ultraviolet phototherapy devices that include Psoria-Light, which is used in targeted PUVA photochemistry and UVB phototherapy for the treatment of skin conditions, such as psoriasis, vitiligo, atopic dermatitis, seborrheic dermatitis, and leukoderma. In addition, it offers intelligent microparticles, which provide technologies within the security and supply chain management vertical sectors; and ActiveDuty, a data intelligence service comprising proprietary, unprecedented, and actionable technology, which include a suite of analytical tools, such as artificial intelligence and social psychology for industries, companies, and agencies. The company was incorporated in 2010 and is based in Tucson, Arizona.